Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2023

NOTE 5 – GOODWILL AND INTANGIBLE ASSETS

The following table provides the gross carrying value of goodwill as follows:

	Amounts
	(in thousands)
Balance at December 31, 2022	$	—
Acquired during the period (see Note 8)		965
Balance at September 30, 2023	$	965

The following table provides the gross carrying amount and accumulated amortization for each major class of intangible asset:

	September 30, 2023		December 31, 2022
	(in thousands)
Intangible assets subject to amortization
Developed technology	$	10,100	$	—
Less: Accumulated amortization		238		—
Total	$	9,862	$	—

Intangible assets not subject to amortization
Internet domain rights	$	120	$	120
Total intangible assets, net	$	9,982	$	120

During the three months ended September 30, 2023, the Company recorded amortization of $238,000.

At September 30, 2023, the related amortization for each of the next five years ended December 31 is as follows (in thousands):